Premium
Botulinum toxin A for pain reduction in pediatric patients with Parry‐Romberg syndrome
Author(s) -
Mishra Kriti,
Sood Arun,
Smidt Aimee,
Price Harper N.
Publication year - 2019
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13746
Subject(s) - medicine , botulinum toxin , reduction (mathematics) , dermatology , anesthesia , mathematics , geometry
Parry‐Romberg syndrome ( PRS ) is characterized by hemiatrophy of facial structures, including skin, subcutaneous fat, muscle, bone, and cartilage. Complications associated with PRS include headaches, seizures, and chronic facial pain. Protocol for the treatment of chronic facial pain is not clear; reports on the use of botulinum toxin A injections for pain reduction in adults but not in the pediatric/adolescent population are available. Here, we discuss two pediatric PRS cases in which treatment with botulinum toxin A injections reduced or eliminated facial pain.